Syra Health (Syra Health) Debt-to-Equity : 0.04 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Syra Health Debt-to-Equity?

Syra Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.13 Mil. Syra Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Syra Health's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $3.45 Mil. Syra Health's debt to equity for the quarter that ended in Mar. 2024 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Syra Health's Debt-to-Equity or its related term are showing as below:

SYRA' s Debt-to-Equity Range Over the Past 10 Years
Min: -23.08 Med: -1.5 Max: 1.32
Current: 0.04

During the past 4 years, the highest Debt-to-Equity Ratio of Syra Health was 1.32. The lowest was -23.08. And the median was -1.50.

SYRA's Debt-to-Equity is ranked better than
88.85% of 547 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs SYRA: 0.04

Syra Health Debt-to-Equity Historical Data

The historical data trend for Syra Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health Debt-to-Equity Chart

Syra Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-21.29

1.32

0.06

Syra Health Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial					-23.08	-2.15	-1.50	0.06	0.04

Competitive Comparison of Syra Health's Debt-to-Equity

For the Medical Care Facilities subindustry, Syra Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syra Health's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Syra Health's Debt-to-Equity falls into.

Syra Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Syra Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.248	+	0)	/	4.013
	=	0.06

Syra Health's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.131	+	0)	/	3.449
	=	0.04

Syra Health (NAS:SYRA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Syra Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Syra Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Syra Health (Syra Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032

Website

https://www.syrahealth.com

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.

Executives

Sandeep Allam	director, officer: President and Chair	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed	10 percent owner	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi	director, officer: Chief Executive Officer	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas	10 percent owner	2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc	10 percent owner	6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad	officer: CFO and COO	1119 KEYSTONE WAY N., #201, CARMEL IN 46032